Business Context and Reporting Period
CareTrust REIT, Inc. (CTRE) is a self-administered REIT focused on acquiring, financing, developing, and owning healthcare-related real estate in the U.S. and U.K. The reporting period covers the quarter and nine months ended September 30, 2025. As of this date, the Company owned or held interests in 399 facilities (SNFs, U.K. Care Homes, ALFs, ILFs) comprising 36,192 beds/units across 32 U.S. states and the U.K.
A material event during the period was the acquisition of Care REIT plc and Impact Health Partners LLP (the "Acquisition"), closed on May 8, 2025, for approximately $595.4 million in cash consideration plus assumed liabilities.
Key Financial Metrics
| Metric (in thousands) | Q3 2025 | Q3 2024 | 9M 2025 | 9M 2024 |
|---|---|---|---|---|
| Total Revenues | $132,444 | $77,381 | $341,534 | $209,342 |
| Net Income (Attributable to CTRE) | $74,901 | $33,441 | $209,248 | $72,945 |
| Diluted EPS | $0.35 | $0.21 | $1.06 | $0.50 |
| Net Cash from Operating Activities | N/A | N/A | $273,069 | $169,043 |
| Cash and Cash Equivalents (End of Period) | $712,480 | $377,102 | $712,480 | $377,102 |
| Total Debt (Principal) | $900,000 | $400,000 | $900,000 | $400,000 |
| Weighted Avg. Interest Rate | 4.29% | N/A | 4.29% | N/A |
Note: Q3 2025 operating cash flow is not explicitly broken out in the provided text, but the 9M figure is available.
Material Changes vs. Prior Period
- Revenue Growth: Total revenues increased 71% in Q3 2025 and 63% in the first nine months of 2025 compared to the prior year periods. This was driven primarily by the Care REIT Acquisition and new loan originations.
- Impairment Charges: Impairment of real estate investments dropped significantly to $0.5 million in Q3 2025 (and 9M 2025) compared to $8.4 million in Q3 2024 and $36.9 million in 9M 2024.
- Debt Structure: Total debt principal increased from $400 million to $900 million. The Company assumed and subsequently repaid approximately $254 million in secured debt related to the Acquisition. It also added a $500 million unsecured term loan facility.
- Equity Issuance: The Company completed an underwritten public offering of 23 million shares in August 2025, raising $736 million in gross proceeds. It also utilized its At-The-Market (ATM) program, raising $370 million in the first nine months of 2025.
- Asset Sales: The Company recorded a net gain on sale of real estate of $3.9 million for the nine months ended September 30, 2025, compared to a loss of $2.3 million in the prior year period.
Guidance, Outlook, and Risks
Management Commentary & Outlook:
- The Company intends to use proceeds from recent equity offerings to fund acquisitions and pay down revolving credit facilities.
- Management expects to maintain compliance with all debt covenants and REIT status requirements.
- Dividends declared were $0.335 per share for each of the first three quarters of 2025.
Risks and Contingencies:
- Regulatory Changes: Medicaid reimbursement rate reductions in Idaho (4%) and North Carolina (3-10%) effective late 2025 could impact tenant financial health. However, the "One Big Beautiful Bill Act" (OBBBA) placed a moratorium on federal minimum staffing standards through 2034, reducing near-term compliance costs.
- Market Risks: Exposure to interest rate fluctuations on variable-rate debt (mitigated by $500 million in interest rate swaps) and foreign exchange risk related to U.K. operations (mitigated by GBP-denominated debt and forward contracts).
- Tenant Concentration: Ensign accounted for 20% of total revenue in the first nine months of 2025.
Unusual Items:
- Accelerated amortization of below-market lease intangibles ($4.4 million) due to lease terminations in August 2025.
- Foreign currency translation gains/losses impacted comprehensive income, with a $4.1 million gain on foreign currency transactions recorded in the nine months ended September 30, 2025.
Investor Verification Checklist
- Acquisition Integration: Verify the accretive impact of the Care REIT plc acquisition on FFO and AFFO, and monitor the integration of U.K. operations.
- Debt Maturities: Confirm the schedule for the $400 million Senior Notes due 2028 and the $500 million Term Loan due 2030, and assess refinancing risks in a high-interest environment.
- Tenant Solvency: Monitor the financial health of major tenants, particularly Ensign (20% revenue concentration), in light of state-level Medicaid rate cuts in Idaho and North Carolina.
- Asset Held for Sale: Review the status of the 8 facilities currently classified as held for sale ($28.1 million carrying value) and potential for further impairment if sales are delayed.
- Equity Dilution: Assess the impact of the recent $736 million public offering and ongoing ATM program on shares outstanding and per-share metrics.